GENEVA, Oct. 27 -- NASUS PHARMA LTD. (9 Harakevet St.6618306 Tel Aviv) filed a patent application (PCT/IL2025/050327) for "SUSTAINED-RELEASE INTRANASAL PHARMACEUTICAL COMPOSITIONS" on Apr 10, 2025. With publication no. WO/2025/220002, the details related to the patent application was published on Oct 23, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): TEMTSIN-KRAYZ, Galia (23 Egoz St.7777112 Ashdod), KAZHDAN, Pavel (62 Ovadia Yosef St.8707621 Sderot), LAPIDOT, Tair (13 Savion St.7171569 Modiin-Macabim-Reut), MEGIDDO, Dalia (5 Nataf St.9080400 M.P. Judean Hills)
Abstract: Pharmaceutical form...